Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care?

Purpose of review Integrated palliative care for those with advanced solid tumors yields significant benefits in patient and caregiver outcomes. However, most palliative care clinical trials have excluded patients with hematologic malignancies. There is growing interest in whether integrated palliative care may yield similar benefits in hematologic malignancy patients and caregivers, but there has been little direct evidence of benefit in this population. This review summarizes new data on palliative care issues in hematologic malignancies, published in the preceding 12 months. Recent findings Most newly published evidence on this topic from the last year is descriptive of unmet needs, poor end-of-life care outcomes or unique differences and issues posed by hematologic malignancies as compared to solid tumors. A few articles describe models of collaborative care in hematologic malignancies, and just one describes the impact of an integrated palliative care intervention on patient and caregiver outcomes. Several studies point to transfusions as a unique and problematic barrier to high-quality end-of-life care in hematologic malignancies. Summary Recent evidence confirms that hematologic malignancy patients have unique and often unmet palliative care needs, and also have worse end-of-life outcomes. More work is needed to develop and test integrated palliative care interventions in this population.
Source: Current Opinion in Supportive and Palliative Care - Category: Palliative Care Tags: BLOOD, BONE MARROW AND LYMPHATICS: Edited by Christopher Dalley Source Type: research

Related Links:

Publication date: Available online 12 October 2019Source: Social Science &MedicineAuthor(s): Kristin Bindley, Joanne Lewis, Joanne Travaglia, Michelle DiGiacomoAbstractAn emphasis on individual intervention and psychological complexity has characterised research on bereavement following an experience of life-limiting illness. Exploration of “structural vulnerability” as a positionality produced by social and structural inequity could provide insights into areas of practice and policy in need of development. This scoping review sought to summarise published research on experiences of social and structural in...
Source: Social Science and Medicine - Category: Psychiatry & Psychology Source Type: research
A phase II trial was proposed to define the efficacy of a short-course radiotherapy for symptomatic palliation of metastatic or locally advanced oesophageal cancer in a low resourced setting where only a 2D-radiotherapy technique was available. Results showed that the delivery of a total dose of 12 Gy in 4 fractions, twice-a-day, over 2 days, ≥ 8 hours apart, was tolerated and effective for the symptomatic palliation of metastatic or locally advanced oesophageal malignancies.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research
Discussions? J Palliat Care. 2019 Oct 10;:825859719880518 Authors: Marks S Abstract Being able to elicit the fundamental values, hopes, and care preferences that drive clinical decision-making for patients with a life-limiting illness is considered a core clinical skill for many specialist and generalist clinicians. Such clinical skills have been described as a crucial component of patient-centered care, especially for those with serious illness who often are confronted with complex and immediate medical decisions. Yet, being able to identify what matters most to a patient or what brings a patient the ...
Source: Journal of Palliative Care - Category: Palliative Care Tags: J Palliat Care Source Type: research
Large cell neuroendocrine carcinoma (LCNEC) and small cell lung carcinoma (SCLC) are aggressive neuroendocrine tumors with poor survival rates [1 –3]. For stage IV SCLC, treatment has not advanced significantly over the last decades and consists of palliative chemotherapy. The same applies to stage IV LCNEC, were no standard treatment exists and palliative chemotherapy with SCLC and non-small cell lung cancer (NSCLC) regimens are both deeme d appropriate [4]. Recently, targeted therapy focusing on delta like protein 3 (DLL3) has received attention to improve outcomes for SCLC and LCNEC [5].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
ConclusionCutaneous metastases secondary to urothelial bladder carcinoma are exceptional especially in its inflammatory presentation. Diagnosis is based on immunohistochemical study. Treatment is based on chemotherapy and the prognosis is poor.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Conclusions: ICU-based end-of-life care resources do not appear to change mortality but are associated with increased hospice utilization. Given that this finding was not confirmed by the instrumental variable analysis, future studies should attempt to verify this finding, and identify specific resources or processes of care that impact the care of ICU patients at the end of life.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Clinical Investigations Source Type: research
Conclusions: In spite of the lack of high-quality evidence, recommendations for pain management at the end-of-life in the ICU are homogeneous and are justified by ethical principles and agreement among experts. Considering the growing demand for the involvement of palliative care teams in the management of the dying patients in the ICU, there is a need to clearly define their early involvement and to further develop comprehensive evidence-based pain management strategies. Based on the study findings, we propose a management algorithm to improve the overall care of dying critically ill patients.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Review Articles Source Type: research
No abstract available
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Editorials Source Type: research
Publication date: Available online 11 October 2019Source: Revista Española de Cardiología (English Edition)Author(s): Samuel D. Slavin, Haider J. WarraichAbstractHeart failure (HF) is a progressive condition with high mortality and heavy symptom burden. Despite guideline recommendations, cardiologists refer to palliative care at rates much lower than other specialties and very late in the course of the disease, often in the final 3 days of life. One reason for delayed referral is that prognostication is challenging in patients with HF, making it unclear when and how the limited resources of specialist palliat...
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
Publication date: Available online 10 October 2019Source: Canadian Journal of CardiologyAuthor(s): Marie-A. Chaix, Michael A. Gatzoulis, Gerhard-Paul Diller, Paul Khairy, Erwin N. OechslinAbstractEisenmenger syndrome is the most severe and extreme phenotype of pulmonary arterial hypertension associated with congenital heart disease. A large non-restrictive systemic left-to-right shunt triggers the development of pulmonary vascular disease, progressive pulmonary arterial hypertension and increasing pulmonary vascular resistance at the systemic level, which ultimately results in shunt reversal. Herein, we review the changing...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Cancer & Oncology | Clinical Trials | Hematology | Palliative | Palliative Care | Study